Why is non-HDL cholesterol considered a better predictor of atherogenic risk than LDL cholesterol in some patients?

• A. Because it includes all apoB-containing lipoproteins such as VLDL, IDL, Lp(a), and LDL.
• B. Because it is unaffected by triglycerides and fasting status.
• C. Because it only reflects HDL particles.
• D. Because it excludes apoB-containing particles.

Answer: (A)

Non-HDL cholesterol captures the cholesterol content of all atherogenic lipoproteins that carry apolipoprotein B in the blood, not just the LDL particles. This includes VLDL, IDL, LDL, and Lp(a). Because cardiovascular risk tracks the number of these apoB-containing particles more closely than the amount of cholesterol in LDL alone, non-HDL cholesterol provides a more complete assessment of atherogenic load, especially when triglyceride-rich remnant particles are elevated. It is calculated from total cholesterol minus HDL cholesterol, so it remains a useful measure across different fasting states and highlights contributions from VLDL and other remnants that would be missed if you looked only at LDL. That broader scope explains why non-HDL cholesterol can be a stronger predictor of atherogenic risk in some patients.